Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Virtus Biotech Clinical Trials ETF
(NY:
BBC
)
43.36
UNCHANGED
Streaming Delayed Price
Updated: 8:00 PM EDT, Mar 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
43.36
Bid (Size)
41.00 (300)
Ask (Size)
68.94 (100)
Prev. Close
43.36
Today's Range
43.36 - 43.36
52wk Range
13.42 - 44.10
Shares Outstanding
4,000
Dividend Yield
1.51%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Did NGNE Stock Surge 25% In Pre-Market Today?
↗
February 27, 2026
The company said that the U.S. Food and Drug Administration granted a key designation for its investigational gene therapy targeting Rett syndrome.
Via
Stocktwits
Why Did UPB Stock Pop 20% In Pre-Market Today?
↗
February 11, 2026
The company announced positive top-line results from its Phase 2 VALIANT trial evaluating Verekitug in adults with severe asthma.
Via
Stocktwits
Performance
YTD
+15.2%
+15.2%
1 Month
+5.9%
+5.9%
3 Month
+10.2%
+10.2%
6 Month
+76.3%
+76.3%
1 Year
+123.9%
+123.9%
More News
Read More
ABUS Stock On Track For Biggest Intraday Drop In Over 5 Years – What’s The Issue Around Its Patent In Europe?
↗
January 16, 2026
Via
Stocktwits
Topics
Intellectual Property
GLUE Stock Slips Pre-Market After Pricing $300 Million Public Offer At Discount
↗
January 09, 2026
Via
Stocktwits
Why Did GLUE Stock Surge Over 50% In Premarket Today?
↗
January 07, 2026
Via
Stocktwits
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
↗
May 07, 2025
Via
Benzinga
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On
↗
April 28, 2025
Via
Benzinga
Topics
ETFs
Economy
Stocks
CureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch Mode
↗
April 10, 2025
Via
Stocktwits
Topics
Government
Why Is uniQure Stock Skyrocketing On Tuesday?
↗
December 10, 2024
Via
Benzinga
Inflation Cools In June, Triggers Spike In Laggard ETFs
↗
July 12, 2024
Via
Talk Markets
Topics
ETFs
Economy
5 ETFs Riding High On The Biotech Comeback
↗
July 09, 2022
Via
Talk Markets
Biotech ETF Tops in June: 5 Stocks That Outperform
↗
June 30, 2022
Via
Talk Markets
4 Sector ETFs That Survived Market Turmoil in June
↗
June 29, 2022
Via
Talk Markets
Frequently Asked Questions
Is Virtus Biotech Clinical Trials ETF publicly traded?
Yes, Virtus Biotech Clinical Trials ETF is publicly traded.
What exchange does Virtus Biotech Clinical Trials ETF trade on?
Virtus Biotech Clinical Trials ETF trades on the New York Stock Exchange
What is the ticker symbol for Virtus Biotech Clinical Trials ETF?
The ticker symbol for Virtus Biotech Clinical Trials ETF is BBC on the New York Stock Exchange
What is the current price of Virtus Biotech Clinical Trials ETF?
The current price of Virtus Biotech Clinical Trials ETF is 43.36
When was Virtus Biotech Clinical Trials ETF last traded?
The last trade of Virtus Biotech Clinical Trials ETF was at 03/10/26 08:00 PM ET
What is the market capitalization of Virtus Biotech Clinical Trials ETF?
The market capitalization of Virtus Biotech Clinical Trials ETF is 173.44K
How many shares of Virtus Biotech Clinical Trials ETF are outstanding?
Virtus Biotech Clinical Trials ETF has 173K shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.